DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ramamurthy C, Handorf EA, Correa AF, Beck JR, Geynisman DM.
Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancer.
Urol Oncol 2019;
37 (10) 688-695
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.